|Articles|September 15, 2009
Retina Roundtable Session 6
Advertisement
Subscribe
In this sixth session, hear the experts’ views on the use of bevacizumab and its related financial issues. (8:20)
Participants include:
Return to
Return to
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























